This move is archived. Current quotes and coverage live on the stock page.
Get ALZI alerts:
Alzai Health Corp. shares surged 17.5% in the last trading session, marking a significant milestone for the healthcare technology company.
In a remarkable turn of events, Alzai Health Corp. (ALZI.V) experienced a substantial increase in its stock price, closing at CA$0.47, up 17.5% from the previous day. This surge reflects growing investor interest in the company's innovative approach to healthcare technology, particularly in addressing cognitive health issues.
Advertisement
Alzai Health Corp.
ALZI.V
ALZI.V
Alzai Health Corp.
WealthAwesomeMarket cap
$23.97M
52W high
$0.50
52W low
$0.28
1W change
+17.46%
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on ALZI's historical volatility
30-Day Vol
113.5%
Annualized
90-Day Vol
111.6%
Annualized
Trend (90d)
-50.0%
Annualized drift
90d Mean
C$0.31
Expected price
| Horizon | Expected | 68% Range (1σ) |
|---|---|---|
| 30 trading days | C$0.35 | C$0.24 – C$0.52 |
| 60 trading days | C$0.33 | C$0.19 – C$0.57 |
| 90 trading days | C$0.31 | C$0.16 – C$0.61 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
Advertisement
Investor takeaway: The recent spike in Alzai Health Corp.'s stock price highlights the potential for growth in the healthcare technology sector, especially as the company continues to develop AI-driven solutions for cognitive impairments.
Alzai Health Corp. stock jumps 17.5% in one day
With a market cap of CA$30.15 million, Alzai Health Corp. is gaining traction in a competitive healthcare technology landscape.
Bull case
Investors are excited about Alzai's technology, which focuses on Mild Cognitive Impairment and Alzheimer's Disease. This suggests there’s a strong market demand for the services they offer.
Bear case
Despite the recent gains, Alzai Health Corp. is still in the early stages of its business. The lack of established revenue streams poses risks for potential investors.
A Closer Look at Alzai Health Corp.
Advertisement
Founded in 2024 and based in Toronto, Alzai Health Corp. specializes in AI-driven risk screening solutions for Mild Cognitive Impairment, Alzheimer's Disease, and Related Dementias. The company recently completed its IPO, raising significant capital to fuel its growth.
Market Sentiment and Future Prospects
The recent stock surge can be attributed to increased investor interest in healthcare technologies that leverage AI. As the population ages, the demand for effective solutions to cognitive health issues is expected to rise, positioning Alzai Health Corp. favorably in the market. However, potential investors should consider the company's current lack of revenue and the inherent risks of investing in early-stage companies.
Understanding the Stock Movement
The 17.5% increase in Alzai Health Corp.'s stock price reflects positive market sentiment. Investors are keenly watching the company's developments as it establishes itself in the healthcare technology sector. For more insights, check out our detailed analysis on Alzai Health Corp..
Best next step
Keep exploring this topic
If you want to go deeper, these are the most useful follow-up pages and tools for this topic.
Broker comparison
Best trading platforms in Canada
Compare $0-commission brokers before you act on a ticker story.
Safe cash
Best GIC rates in Canada
If the story makes you want to de-risk, compare guaranteed rates next.
HISA roundup
Best high-interest savings accounts
Keep dry powder in a no-fee savings account instead of chequing.
TFSA room
Check TFSA contribution room
Shelter the next contribution before you buy.
Advertisement
Wealth Awesome
Timely coverage of Canadian stocks, earnings, dividends, and market movers for DIY investors. Stories are checked against exchange data and public filings.
View Full Profile →✅ Reviewed by Certified Financial Professionals
This content has been reviewed by CFA® charterholders and Certified Financial Planners (CFP®) with over a decade of experience in Canadian financial markets. All information is fact-checked against official Canadian sources and regulations.
Why these credentials matter: CFA® charterholders complete 900+ hours of rigorous study in investment analysis and ethics. CFP® professionals are held to the highest standards of financial planning competency and fiduciary duty in Canada.
⚠️ Professional Disclaimer
This content is for educational purposes only and should not be considered personalized financial advice. While our team brings professional expertise, individual circumstances vary. For personalized guidance, consult with a qualified financial advisor, tax professional, or mortgage specialist.
